These KRASG12D-related engineered exosomes (also termed as iExosomes), together with the modification of CD47 peptides on the surface of iExosomes for escaping phagocytosis, can significantly suppress tumor growth in multiple mouse models of pancreatic cancer and support increased survival (70). This evidence concerns the gene CD47 and neoplasm.